Biontech stock

Stock Price Statistics The stock price has decreased by -14.48% in the last 52 weeks. The beta is 0.26, so BioNTech SE's price volatility has been lower than the market average..

BNTX stock analysts projected a per-share loss of 30 cents. BioNTech blamed write-offs to partner Pfizer for the profit and sales hits. On today's stock market, BNTX stock toppled 7.5% to 98.50 ...Shares traded 424.39k. 1 Year change -19.68% Beta 0.2477. Data delayed at least 15 minutes, as of May 01 2024 21:00 BST. Find More Stocks. Use our equities screener to …Get the latest information on BioNTech SE (BNTX), a German biotechnology company that develops mRNA-based vaccines and therapies. See its stock performance, financial results, news, analysis, …

Did you know?

May 10, 2024 · BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh Mar. 20, 2024 at 7:30 a.m. ET by Tomi Kilgore Biontech 4Q Rev EUR1.48B Find out all the key statistics for BioNTech SE (BNTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta (5Y ... Q1 2024 BioNTech SE Earnings Call. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript. BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to BioNTech’s First Quarter 2024 Earnings Call.

BioNTech Se is a German biotech company that develops immunotherapies for cancer and other diseases. It also produces COVID-19 vaccines and has a partnership with Pfizer. …Mar 20, 2024 ... BioNTech said that writedowns of inventory from its partner Pfizer (PFE) lowered revenue by 291.3 million euros ($315.9 million) in the quarter.A major windfall. Based in Germany, BioNTech was originally founded in 2008 and made its debut on the stock market in the U.S. in late 2019. It was a relatively unknown company then, but its ... BioNTech SE (BNTX) is a publicly traded biotechnology business based in the US. It opened the day at $92.56 after a previous close of $91.67. During the day the price has varied from a low of $92.4132 to a high of $93.48. The latest price was $92.72 (25 minute delay). BioNTech is listed on the NASDAQ and employs 6,133 staff.

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific …Track BioNTech SE - ADR (BNTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Biontech stock. Possible cause: Not clear biontech stock.

BioNTech expects to release third-quarter results on Nov. 6. BioNTech's stock has dropped 31.1% year to date through Friday, while Pfizer shares have tumbled 37.3% and the S&P 500 has gained 12.7% ...BioNTech stock tumbled to its lowest point in three years Wednesday after the Covid vaccine maker reported light fourth-quarter sales and profit, and delivered lackluster 2024 guidance.. X. The ...

Open 84.75. Bid 84.35 x -- Ask 86.05 x -- Day's Range 84.75 - 86.00. 52 Week Range 77.50 - 116.00. Volume 106. Avg. Volume 1,190. Market Cap (intraday) 20.713B. Beta …BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies includ ing mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific …Find the latest BioNTech SE (22UA.F) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …View the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

The company affirmed its full-year guidance of revenue between EUR2.5 billion and EUR3.1 billion ($2.7 billion and $3.3 billion). BioNTech ADRs have lost about …Scientific journal Nature on Wednesday said a personalised treatment based on messenger RNA by BioNTech potentially bodes well for the future of ... AMC soar as meme stock rally roars on 9:15 ...SPX. +0.48%. Shares of BioNTech SE sank toward a more than two-year low Wednesday, after the Germany-based biotechnology company reported fourth-quarter results that fell sharply below ...

BioNTech's stock has underperformed the broader market as it is off 27% in the last year compared to the SP500 being up 32%. StockCharts.com Per Fintel, BioNTech's short interest makes up 3.38% of ...The average analyst rating for BioNTech SE stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market ...Because of that gap in time -- and the risk of failures during clinical trials -- determining whether BioNTech stock is a buy is less about valuation and more about the open-ended potential of a ...

los angeles to shanghai BNTX. -0.47%. On Monday, Evercore ISI began coverage on shares of BioNTech (NASDAQ: BNTX ), assigning an "In Line" rating and setting a price target of $100. The firm's analysis pointed to the ... libreoffice office 5:53 AM. BioNTech (Filer) Form 6-K. Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. (Data available from 1/1/2016 forward) This page (NASDAQ:BNTX) was last updated on 5/8/2024 by MarketBeat.com Staff.Contact. For any further questions, you can reach us daily from 12:00 to 16:00 CET under +49 6131 9084-1291. Alternatively, you can also send us an email: [email protected]. Go to contact form. Join us on our mission to improve global health by developing the next generation of immunotherapies and vaccines. BioNTech is growing - and this creates ... typing club com A major windfall. Based in Germany, BioNTech was originally founded in 2008 and made its debut on the stock market in the U.S. in late 2019. It was a relatively unknown company then, but its ...If BioNTech exercises an option, Autolus will be eligible to receive exercise fees and milestones payments, with low-single digit royalties on net sales of the licensed products. About BioNTech’s cell and gene therapy portfolio BioNTech has been active in the development of cell and gene therapies since 2009. get free sms online BioNTech (BNTX) Stock Price, News & Analysis. → Millionaire investor and Republican donor makes surprising election prediction (From InvestorPlace) Free BNTX … ladies in lavender BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by about 2% over the last week (five trading days) and also remains down by about ...80.90%. -16.75%. -163.26%. -35.78%. -95.66%. Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for BioNTech SE (BNTX). See many years of revenue, expenses and profits or losses. how do you make a photo collage BioNTech Analyst EPS Estimates. BioNTech last announced its quarterly earnings results on March 20th, 2024. The reported $2.05 earnings per share for the …See BioNTech SE (BNTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.The 12-month price targets, analyzed by analysts, offer insights with an average target of $116.6, a high estimate of $133.00, and a low estimate of $99.00. Experiencing a 11.83% decline, the ... healthy wager Stock Information Stock Quote & Chart Stock Quote & Chart. Change ... BioNTech SE. An der Goldgrube 12. 55131 Mainz, Germany. T: +49 6131 9084-0. F: +49 6131 9084-2121. different language ... Stock BNTX BIONTECH SE. PDF Report. Consensus BioNTech SE. Equities. BNTX. US09075V1026. Delayed Nasdaq. Other stock markets. 01:33:33 2024-05-07 pm EDT, 5-day ... what is private browsing NasdaqGS - NasdaqGS Real-time price. Currency in USD. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Discover extensive information about BioNTech share price (BNTX) using our intuitive Charts, Technical Analysis, Historical data, BioNTech stock Reports and more. dream sockjfk to zurich On today's stock market, BNTX stock dipped 0.4% and closed at 108.05. BNTX Stock: Lower Boosting Levels Expected. The Pfizer -partnered Covid shot is BioNTech's only commercial product. BioNTech's ...Find out all the key statistics for BioNTech SE (BNTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta (5Y ... babel tower game Why BioNTech Stock Was Sinking Today. Why Shares of BioNTech Rose Friday. 2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years. Why Shares of BioNTech Slumped Monday. mygolo account May 10, 2024 · BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh Mar. 20, 2024 at 7:30 a.m. ET by Tomi Kilgore Biontech 4Q Rev EUR1.48B flying to oakland ca If BioNTech exercises an option, Autolus will be eligible to receive exercise fees and milestones payments, with low-single digit royalties on net sales of the licensed products. About BioNTech’s cell and gene therapy portfolio BioNTech has been active in the development of cell and gene therapies since 2009. Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis. flight to australia A major windfall. Based in Germany, BioNTech was originally founded in 2008 and made its debut on the stock market in the U.S. in late 2019. It was a relatively unknown company then, but its ... metv + Since its IPO last October, the stock price of COVID-19 vaccine and oncological treatment developer BioNTech ( BNTX 0.74%) was up by more than 489% as of market close on Oct. 27. That's …Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...SPX. +0.48%. Shares of BioNTech SE sank toward a more than two-year low Wednesday, after the Germany-based biotechnology company reported fourth-quarter results that fell sharply below ... coffee shop nearby BioNTech Se is a German biotech company that develops immunotherapies for cancer and other diseases. It also produces COVID-19 vaccines and has a partnership with Pfizer. …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th... red robyn RATIOS/PROFITABILITY. EPS (TTM) 39.99. P/E (TTM) 2.26. Fwd P/E (NTM) -37.86. EBITDA (TTM) -188.805M. ROE (TTM) 0.56%. Revenue (TTM) 2.935B. Gross Margin (TTM) 79.38%. Net Margin (TTM) 4.14%.BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific … bijou brigitte The intraday chart, the last-five real-time quotes and sales data. Real-time stock quotes can be used to help inform investors when researching potential investment opportunities. BioNTech SE ... temple golden temple Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.5, a high estimate of $171.00, and a low estimate of $99.00. This current average has decreased by ...BioNTech ended 2023 with approximately €17.5 billion (unaudited) in cash, cash equivalents and security investments. The Company plans to maintain a strong financial position and generate ...Pfizer Inc’s (NYSE:PFE) German partner, BioNTech SE (NASDAQ:BNTX), reported fourth-quarter 2023 EPS of fiscal year Q4 GAAP EPS of €1.90 versus €9.26, a year ago, equivalent to $2.04 missing ...]